Incurring greater health care costs: risk stratification of employees with bipolar disorder

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 8, Issue 1, 2006, Pages 17-24

  Brook, Richard A ^a   Rajagopalan, Krithika ^c   Kleinman, Nathan L ^d   Smeeding, James E ^b   Brizee, Truman J ^d   Gardner, Harold H ^d  

^a JeSTARx Group   (United States)

^b JestaRx Group   (United States)

^c ASTRAZENECA   (United Kingdom)

^d Human Capital Management Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISEASE SEVERITY; EMPLOYEE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PRESCRIPTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; WORKMAN COMPENSATION;

EID: 33645232093     PISSN: 15235998     EISSN: None     Source Type: Journal    
DOI: 10.4088/pcc.v08n0103     Document Type: Article

References (38)

1. Goodwin GM. Prophylaxis of bipolar disorder: how and who should we treat in the long term? Eur Neuropsychopharmacol 1999;9:S125-S129
2. Griswold KS, Pessar LF. Management of bipolar disorder. Am Fam Physician 2000;62:1343-1353, 1357-1358
3. Sachs GS. A 25-year-old woman with bipolar disorder. JAMA 2001;285:454-462
4. Narrow WE, Rae DS, Robins LN, et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002;59:115-123
5. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003;73:123-131
6. Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94
7. Regier DA, Hirschfeld RM, Goodwin FK, et al. The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis. Am J Psychiatry 1988;145:1351-1357
8. Calabrese JR, Hirschfeld RM, Reed M, et al. Impact of bipolar disorder on a US community sample. J Clin Psychiatry 2003;64:425-432
9. Coryell W, Scheftner W, Keller M, et al. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993;150:720-727
10. Kleinman NL, Brook RA, Rajagopalan K, et al. Lost time, absence costs, and reduced productivity output for employees with bipolar disorder. J Occup Environ Med 2005;47:1117-1124
11. Kleinman L, Lowin A, Flood E, et al. Costs of bipolar disorder. Pharmacoeconomics 2003;21:601-622
12. Begley CE, Annegers JF, Swann AC, et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 2001;19:483-495
13. Peele PB, Xu Y, Kupfer DJ. Insurance expenditures on bipolar disorder: clinical and parity implications. Am J Psychiatry 2003;160:1286-1290
14. Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord 2002;4:398-405
15. Matza L, de Lissovoy G, Sasane R, et al. The impact of bipolar disorder on work loss. Drug Benefit Trends 2004;16:476-481
16. Birnbaum HG, Shi L, Dial E, et al. Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis. J Clin Psychiatry 2003;64:1201-1209
17. Goetzel RZ, Hawkins K, Ozminkowski RJ, et al. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 2003;45:5-14
18. de Zelicourt M, Dardennes R, Verdoux H, et al. Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France. Pharmacoeconomics 2003;21:1081-1090
19. Bhugra D, Flick GR. Pathways to care for patients with bipolar disorder. Bipolar Disorders 2005;7:236-245
20. Rush AJ. Toward an understanding of bipolar disorder and its origin. J Clin Psychiatry 2003;64(suppl 6):4-8
21. Zylstra RG, Sanford CE. Bipolar II disorder in a primary care setting: clinical vignette. Prim Care Companion J Clin Psychiatry 1999;1:47-49
22. Brady KT. Difficulties in diagnosis and management of bipolar disorder: three case presentations. J Clin Psychiatry 2000;61(suppl 13):32-37
23. Barbato N, Hafner RJ. Comorbidity of bipolar and personality disorder. Aust N Z J Psychiatry 1998;32:276-280
24. Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord 2002;68:1-23
25. McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001;158:420-426
26. Sherwood Brown E, Suppes T, Adinoff B, et al. Drug abuse and bipolar disorder: comorbidity or misdiagnosis? J Affect Disord 2001;65:105-115
27. Health Insurance Portability and Accountability Act, 42 USC § 1320-d2 (1996)
28. World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO;1997
29. The Fair Labor Standards Act (FLSA). US Department of Labor. Available at http://www.dol.gov/dol/compliance/comp-flsa.htm. Accessed March 14, 2005
30. Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ 1999;18:153-171
31. Manning JS, Connor PD, Sahai A. The bipolar spectrum: a review of current concepts and implications for the management of depression in primary care. Arch Fam Med 1998;7:63-71
32. Ai C, Norton E. Standard errors for the retransformation problem with heteroscedasticity. J Health Econ 2000;19:697-718
33. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003;64:161-174
34. Hirschfeld RM. The Mood Disorder Questionnaire: A simple, patientrated screening instrument for bipolar disorder. Prim Care Companion J Clin Psychiatry 2002;4:9-11
35. Hirschfeld RMA. Bipolar depression: the real challenge. Eur Neuropsychopharmacol 2004;14:83S-88S
36. Post RM, Frye MA, Denicoff KD, et al. Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology 1998;19:206-219
37. Fankhauser MP. Bipolar disorder. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 5th ed. New York, NY: McGraw-Hill; 2002:1273
38. Belmaker RH. Bipolar disorder. N Engl J Med 2004;351:476-486